» Articles » PMID: 4006105

Removal of the Endothelium Potentiates Canine Large Coronary Artery Constrictor Responses to 5-hydroxytryptamine in Vivo

Overview
Journal Circ Res
Date 1985 Jul 1
PMID 4006105
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies in isolated epicardial coronary artery rings have shown that the endothelium modulates vasomotor responses to certain endogenous neurohumoral agents. It is not known whether the endothelium plays a role in large coronary vasoregulation in the intact coronary circulation. Accordingly, we examined effects of endothelial removal on vasoconstrictor responses of the proximal coronary artery in anesthetized adult mongrel dogs. The left anterior descending artery was perfused at 100 mm Hg with arterial blood from a pressurized reservoir. Coronary diameter was measured continuously with 7-MHz sonomicrometer crystals attached to the adventitia of the artery. Fifteen minutes after mechanical disruption of the endothelium with a balloon-tipped catheter, baseline diameter was unchanged from a control value of 2.60 +/- 0.13 mm (mean +/- SE, n = 17). Endothelial denudation resulted in a dose-dependent potentiation of the constrictor response to intracoronary 5-hydroxytryptamine (1-50 micrograms/min, n = 8). With the endothelium intact, a 5 micrograms/min infusion of 5-hydroxytryptamine reduced diameter by 24 +/- 14 micron, while a 50 micrograms/min dose reduced diameter by 54 +/- 25 micron. After endothelial removal, the decrease in diameter averaged 74 +/- 18 microns at 5 micrograms/min and 132 +/- 29 micron at 50 micrograms/min, indicating a 10-fold increase in the sensitivity to 5-hydroxytryptamine. The constrictor responses to angiotensin II (1 and 5 micrograms/min, n = 7) and phenylephrine (1-5 micrograms/min, n = 7) were not altered by endothelial removal. Thus, endothelial removal selectively potentiates the constrictor responses to 5-hydroxytryptamine in the intact coronary circulation of the dog.

Citing Articles

Effects of Catheterization on Artery Function and Health: When Should Patients Start Exercising Following Their Coronary Intervention?.

Tryfonos A, Green D, Dawson E Sports Med. 2019; 49(3):397-416.

PMID: 30719682 DOI: 10.1007/s40279-019-01055-3.


Mechanisms of augmented vasoconstriction induced by 5-hydroxytryptamine in aortic rings from spontaneously hypertensive rats.

Budzyn K, Ravi R, Miller A, Sobey C Br J Pharmacol. 2008; 155(2):210-6.

PMID: 18552867 PMC: 2538692. DOI: 10.1038/bjp.2008.247.


Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Villalon C, Centurion D Naunyn Schmiedebergs Arch Pharmacol. 2007; 376(1-2):45-63.

PMID: 17703282 DOI: 10.1007/s00210-007-0179-1.


The effect of tezosentan, a non-selective endothelin receptor antagonist, on shear stress-induced changes in arterial diameter of the anaesthetized dog.

Markos F, Hennessy B, Fitzpatrick M, OSullivan J, Snow H J Physiol. 2002; 544(3):913-8.

PMID: 12411533 PMC: 2290630. DOI: 10.1113/jphysiol.2002.030478.


Characteristics of arterial wall shear stress which cause endothelium-dependent vasodilatation in the anaesthetized dog.

Snow H, Markos F, ORegan D, Pollock K J Physiol. 2001; 531(Pt 3):843-8.

PMID: 11251063 PMC: 2278506. DOI: 10.1111/j.1469-7793.2001.0843h.x.